PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 200 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $15,001,000 | -21.3% | 399,496 | 0.0% | 3.16% | +15.8% |
| Q2 2017 | $19,056,000 | +4.6% | 399,496 | 0.0% | 2.73% | +9.2% |
| Q1 2017 | $18,217,000 | -27.3% | 399,496 | -48.5% | 2.50% | -45.4% |
| Q4 2016 | $25,045,000 | -5.6% | 775,388 | 0.0% | 4.58% | -5.4% |
| Q3 2016 | $26,534,000 | +1.5% | 775,388 | 0.0% | 4.84% | +36.2% |
| Q2 2016 | $26,154,000 | -38.9% | 775,388 | -4.0% | 3.55% | -16.8% |
| Q1 2016 | $42,789,000 | -24.7% | 807,650 | +9.1% | 4.27% | +7.8% |
| Q4 2015 | $56,825,000 | +94.7% | 740,000 | +4.2% | 3.96% | +92.3% |
| Q3 2015 | $29,181,000 | -4.2% | 710,000 | +64.9% | 2.06% | +19.6% |
| Q2 2015 | $30,447,000 | +21.4% | 430,535 | +52.5% | 1.72% | +12.0% |
| Q1 2015 | $25,081,000 | +1755.1% | 282,284 | +1750.8% | 1.54% | +2037.5% |
| Q4 2014 | $1,352,000 | +143.2% | 15,252 | +166.1% | 0.07% | +140.0% |
| Q3 2014 | $556,000 | +5.5% | 5,732 | 0.0% | 0.03% | -9.1% |
| Q2 2014 | $527,000 | -39.1% | 5,732 | -53.6% | 0.03% | -59.3% |
| Q1 2014 | $865,000 | +64.1% | 12,366 | +35.0% | 0.08% | +107.7% |
| Q4 2013 | $527,000 | – | 9,160 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |